Funding for this research was provided by:
National Institutes of Health (R01DA045465)
SCORE Career Enhancement Core Program (U54AA027989)
Received: 3 January 2022
Accepted: 4 April 2022
First Online: 13 April 2022
: This study was approved by Yale University’s Human Investigations Committee, Radioactive Drug Research Committee, and Radiation Safety Committee. Informed consent was obtained prior to the performance of any study procedures.
: Not applicable.
: The authors declare no conflict of interest.